127 related articles for article (PubMed ID: 6895717)
21. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
Omura GA; Bartolucci AA; Lessner HE; Hill GJ
Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369
[No Abstract] [Full Text] [Related]
22. m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program.
Weiss RB; Charles LM; Macdonald JS
Cancer Clin Trials; 1980; 3(3):203-9. PubMed ID: 7002337
[TBL] [Abstract][Full Text] [Related]
23. Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
Hilgers RD; Legha SS; Boutselis JG; Hannigan EV; Stephens RL; Tranum BL; Surwit E
Cancer Treat Rep; 1984 Feb; 68(2):443-4. PubMed ID: 6546533
[No Abstract] [Full Text] [Related]
24. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
25. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
Warrell RP; Straus DJ; Young CW
Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
[TBL] [Abstract][Full Text] [Related]
26. m-AMSA in refractory lymphoma. A phase II trial of the Eastern Cooperative Oncology Group.
Keller AM; Tsiatis AA; Neiman RS; Glick JH; Mann RB
Am J Clin Oncol; 1985 Oct; 8(5):449-52. PubMed ID: 3840644
[TBL] [Abstract][Full Text] [Related]
27. Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
Kramer BS; Birch R; Einhorn L; Greco A
Cancer Treat Rep; 1985 Mar; 69(3):333-4. PubMed ID: 2983895
[No Abstract] [Full Text] [Related]
28. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
[No Abstract] [Full Text] [Related]
29. Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.
Schneider RJ; Woodcock TM; Howerd J; Ochoa M
Cancer Treat Rep; 1982 Jul; 66(7):1589-90. PubMed ID: 6896470
[No Abstract] [Full Text] [Related]
30. Treatment of advanced colorectal carcinoma with AMSA.
Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
[TBL] [Abstract][Full Text] [Related]
31. Amsacrine (AMSA).
Issell BF
Cancer Treat Rev; 1980 Jun; 7(2):73-83. PubMed ID: 6931632
[No Abstract] [Full Text] [Related]
32. Phase II study of AMSA in patients with metastatic malignant melanoma.
Houghton AM; Camacho F; Wittes R; Young CW
Cancer Treat Rep; 1981; 65(1-2):170-1. PubMed ID: 6894401
[No Abstract] [Full Text] [Related]
33. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
[TBL] [Abstract][Full Text] [Related]
34. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
Friedman MA; Marcus F; Kohler M; Resser KJ
Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
[No Abstract] [Full Text] [Related]
35. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of amsacrine gluconate in refractory leukemia.
Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
Inamasu M; Oishi N; Chen T; Legha S; McCracken J; Balcerzak S; Stephens R; O'Bryan R; Rivkin SE; Costanzi JJ
Cancer Treat Rep; 1984 Nov; 68(11):1411-2. PubMed ID: 6548661
[No Abstract] [Full Text] [Related]
38. Pediatric oncology group phase II trial of amsacrine in children with solid tumors.
Civin CI; Krischer JP; Land VJ; Nitschke R; Kamen B; Vats T
Cancer Treat Rep; 1985 Mar; 69(3):335-6. PubMed ID: 3838498
[No Abstract] [Full Text] [Related]
39. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
Cheng E; Lightdale C; Young C; Yagoda A; Fortner J; Golbey R
Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
[No Abstract] [Full Text] [Related]
40. Amsacrine (AMSA)--a clinical review.
Louie AC; Issell BF
J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
